FPR1 and systemic inflammatory response syndrome: Peptide deformylase, a metalloenzyme, has the inherent activity to degrade NFPs before they bind FPR-1, and may in fact serve as a potential pharmacologic agent for the treatment of trauma-induced SIRS and sepsis.